Considerations for current and future management of haemophilia and its complications
- 1 January 1995
- journal article
- Published by Wiley in Haemophilia
- Vol. 1 (1) , 2-10
- https://doi.org/10.1111/j.1365-2516.1995.tb00032.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Management of haemophilia in developing countries with available resourcesHaemophilia, 1995
- The role of gene therapy in haemophiliaHaemophilia, 1995
- Management of patients with HIV and/or hepatitisHaemophilia, 1995
- B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentratesThe Lancet, 1994
- Current status of prophylaxis for opportunistic infections in HIV-infected patientsAIDS, 1994
- Pharmacokinetic dosing in prophylactic treatment of hemophilia AEuropean Journal of Haematology, 1993
- Clinical Evaluation of Viral Safety of Coagulation Factor VIII and IX ConcentratesVox Sanguinis, 1993
- Gene therapy for human inherited disorders: techniques and statusCritical Reviews in Oncology/Hematology, 1992
- Transmission of Human Parvovirus B19 by Coagulation Factor ConcentratesVox Sanguinis, 1990
- Chronic Bone Marrow Failure Due to Persistent B19 Parvovirus InfectionNew England Journal of Medicine, 1987